Supplemental Figure 1 from First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors

Autor:	David M. Goldenberg, Robert M. Sharkey, Steven A. Hamburger, William A. Wegener, Pius P. Maliakal, Serengulam V. Govindan, Sajeve S. Thomas, Linda T. Vahdat, Vincent J. Picozzi, Michael J. Guarino, Manish A. Shah, Allyson J. Ocean, Alexander N. Starodub
Rok vydání:	2023
DOI:	10.1158/1078-0432.22457156
Popis:	Trop-2 expression in archived tissue specimens from 6 patients enrolled in the clinical trial with sacituzumab govitecan.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0a91efb968a0bf05043b6d26295d33c https://doi.org/10.1158/1078-0432.22457156 Zobrazit plný text záznamu